Severity
Moderate
FDA Drug recall · Reported September 21, 2022
CGMP Deviations: Product complaints reporting the product to have a gritty texture and lack of effectiveness.
Direct Rx recalled Triamcinolone Acetonide cream, 0.1%, 80 g tube, Rx only, Packaged and Distributed By: Dir… - a moderate-severity action.
Triamcinolone Acetonide cream, 0.1%, 80 g tube, Rx only, Packaged and Distributed By: Dir… was recalled by Direct Rx in September 21, 2022. Reason: CGMP Deviations: Product complaints reporting the product to have a gritty texture and lack of effectiveness.. Check the official notice for the remedy. Verify recall #D-1535-2022 with the FDA Drug before acting.
The recall
Direct Rx issued this moderate-severity FDA Drug recall-CGMP Deviations: Product complaints reporting the product to have a gritty texture and lack of effectiveness..
Sourced from official FDA Drug enforcement records. Verify recall #D-1535-2022 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-1535-2022) was formally reported on September 21, 2022, with the manufacturer initiating the action on September 12, 2022. It is classified under Moderate severity (Class II), with a current status of Completed. Direct Rx is listed as the recalling firm, operating out of Dawsonville, GA. Federal records list the affected scope as 20 tubes.
The documented reason for this recall is: CGMP Deviations: Product complaints reporting the product to have a gritty texture and lack of effectiveness. Distribution data in the federal record shows the product reached: Physicians and Medical Facilities in GA and ID. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 3 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 1,360 cosmetics & personal care recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
20 tubes
Related Recalls
6
3 from same agency
Triamcinolone Acetonide cream, 0.1%, 80 g tube, Rx only, Packaged and Distributed By: Direct Rx, Dawsonville, GA 30534, Dist. By Perrigo, Allegan, MI 49010, NDC 72189-330-80.
CGMP Deviations: Product complaints reporting the product to have a gritty texture and lack of effectiveness.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Completed |
| Recall number | D-1535-2022 |
| Date reported | September 21, 2022 |
| Date initiated | September 12, 2022 |
| Recalling firm | Direct Rx |
| Firm location | Dawsonville, GA |
| Affected scope | 20 tubes |
| Distribution | Physicians and Medical Facilities in GA and ID |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
· 2026-06-04
PS Seasoning & Spices, Inc. · 2026-05-27
Fontana Flavors, Inc · 2026-05-27
Wisconsin Pharmacal Company · 2026-05-27
SUN PHARMACEUTICAL INDUSTRIES INC · 2026-04-22
Compare this recall with Tiny Land Children's Play Tents Recalled Due to Risk of Inj… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported September 21, 2022. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.